Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 100.50
+2.50 (2.55%)
May 29, 2026, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 156.41 billion as of May 29, 2026. Its market cap has increased by 65.31% in one year.
Market Cap
156.41B
Enterprise Value
151.53B
Revenue
38.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
100.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 156.41B, an increase of 1,865.40%. That is a compound annual growth rate of 138.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 156.41B | -34.89% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 43.23B |
| Lin BioScience | 30.85B |
| Oneness Biotech | 23.82B |
| Lumosa Therapeutics | 20.77B |
| Sunmax Biotechnology | 20.70B |
| Medigen Vaccine Biologics | 14.53B |
| CHO Pharma | 13.87B |
| TaiMed Biologics | 12.87B |